November 28, 2023
Revax Biotech Ultra-Low Dose Vaccine Technology can make World Vaccination a Reality
Revax Biotech announce their response to the G7/WHO Challenge enabling vaccines to be available to meet existing or emerging respiratory pandemic threats in 100 days or less. Revax Biotech is a UK...